The Trump administration has intervened in the release of important studies on the bird flu, as an outbreak escalates across the United States.

At first, much the same. But inevitably, dangerous diseases would resurge in a country that isn’t prepared for them.

Former NYC Health Commissioner Dr. Ashwin Vasan explores what Trump’s nominations of RFK Jr. and David Weldon mean for health ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load.